![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, January 23, 2023 10:39:46 AM
<<<<<<<<<< but nobody would prescribe it >>>>>>>>>
The National NHS approved ActiPatch under their Drug Tariff. It was the Local NHS bureaucracy, CCGs, who stopped doctors from prescribing ActiPatch with the same excuse that US health Insurers use, 'more, larger clinical studies are needed to confirm efficacy'.
It is more likely that the CCG decision was based on cost issues as their budgets have been cut over the last 15 years due to lower UK tax revenues. They seem to feel that more availability of Drugs/Devices to their patients means more expenses that they can't afford.
ActiPatch is not the only Device/Drug that the CCGs would not approve. Each time a new Drug Tariff is issued by the National NHS the CCGs deny the use of hundreds of new Drugs/Devices.
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM